The shorters/downrampers are throwing a lot of no evidence backed 'bagging' lines around concerning the Pitt report.
They must have missed the part where Pitt Street values BRN as a 7 bagger from here...... or they did read it, and it just makes them mad as hell.
Or maybe they missed the AI at the Edge expected exponential growth or perhaps BRN's 1st mover advantage or maybe the Patent portfolio.
Could the disclosure at the AGM that engagements were closing in on decisions upsetting them?
Or maybe they are just AI at the Edge deniers?
Perhaps they resent BRN being a US and International focussed business but listed as an Australian company on the ASX.
The list goes on and on.
- Forums
- ASX - By Stock
- The market has (apparently) got the value of BRN wrong
The shorters/downrampers are throwing a lot of no evidence...
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $552.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 27.5¢ | $6.297M | 22.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 1370975 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1073647 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1320975 | 0.275 |
48 | 1391142 | 0.270 |
14 | 575137 | 0.265 |
16 | 333306 | 0.260 |
7 | 126883 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1073647 | 14 |
0.290 | 678311 | 14 |
0.295 | 941871 | 17 |
0.300 | 1088061 | 27 |
0.305 | 934255 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online